Nicolas Rognin
14Patents
4h-index
11Co-inventors
53Inventor score
Filing activity: Aug 5, 2005 → Oct 22, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8036437B2 | Perfusion assessment method and system based on animated perfusion imaging | Physics | 21 | Active |
| US7912259B2 | Image registration method and apparatus for medical imaging based on multiple masks | Physics | 15 | Active |
| US9307957B2 | Auto-scaling of parametric images | Physics | 5 | Active |
| US9198639B2 | Detection of immobilized contrast agent in medical imaging applications based on flow dynamics analysis | Human Necessities | 4 | Active |
| US8512249B2 | Detection of the detachment of immobilized contrast agent in medical imaging applications | Physics | 3 | Active |
| US10130342B2 | Initialization of fitting parameters for perfusion assessment based on bolus administration | Physics | 3 | Active |
| US8021303B2 | System for extracting morphological information through a perfusion assessment process | Human Necessities | 3 | Active |
| US8496591B2 | Perfusion assessment method and system based on bolus administration | Human Necessities | 1 | Active |
| US10278612B2 | Real-time perfusion imaging and quantification | Physics | 0 | Active |
| US9192357B2 | Method and system for quantitative vectorial perfusion based upon blood flow direction using 4D medical imaging | Human Necessities | 0 | Active |
| US8929634B2 | Parametric images based on dynamic behavior over time | Physics | 0 | Active |
| US7846100B2 | Medical imaging system based on a targeted contrast agent | Emerging Cross-Sectional Technologies | 0 | Active |
| US11607196B2 | Initialization of fitting parameters for perfusion assessment based on bolus administration | Physics | 0 | Active |
| US8634608B2 | Instantaneous visualization of contrast agent concentration in imaging applications | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.